Login / Signup

Therapeutic drug monitoring guidelines in oncology: what do we know and how to move forward? Insights from a systematic review.

Xinya LiZaiwei SongZhan-Miao YiJiguang QinDan JiangZhitong WangHuibo LiRongsheng Zhao
Published in: Therapeutic advances in medical oncology (2024)
From the perspective of current guidelines, TDM in oncology is now being expanded from cytotoxic antineoplastic drugs to newer targeted treatments. Whereas, the types of antineoplastic drugs involved are still small, and there is still room for quality improvement. Furthermore, the reflected gaps warrant future studies into the exposure-response relationships and population pharmacokinetics models.
Keyphrases
  • quality improvement
  • palliative care
  • clinical practice
  • current status
  • case control
  • drug induced
  • drug delivery